Values-Affirmation Intervention Targeting Medication Adherence in Older Adults With Heart Failure
Feasibility and Acceptability of a Values-Affirmation Intervention Targeting Medication Adherence in Older Adults With Heart Failure
1 other identifier
interventional
7
1 country
1
Brief Summary
Heart failure (HF) represents a significant public health concern. Medication non-adherence represents a modifiable contributor to costly hospital readmissions in older adults with HF. Educational interventions improve, but do not eliminate, non-adherence. Values affirmation interventions which invite individuals to reflect on core values may encourage better engagement in health behaviors by increasing the personal relevance of targeted behaviors. Similar interventions have promoted weight loss, increased adherence and physical activity, and more frequent fruit and vegetable consumption in a variety of contexts and populations. This study seeks to test a recently developed values-affirmation intervention targeting medication adherence in older adults with HF enrolled in cardiac rehabilitation (CR). The purpose of this feasibility study is to test methodology to aid development of a subsequent randomized controlled pilot trial to examine preliminary efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable heart-failure
Started Feb 2022
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 23, 2022
CompletedFirst Submitted
Initial submission to the registry
March 22, 2022
CompletedFirst Posted
Study publicly available on registry
April 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2022
CompletedResults Posted
Study results publicly available
June 22, 2023
CompletedJune 22, 2023
September 1, 2022
6 months
March 22, 2022
May 2, 2023
May 30, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Feasibility of Recruitment Procedures
Proportion of eligible participants who enroll in the study
Baseline
Feasibility of Intervention Procedures
Proportion of enrolled participants who complete the study
Week 4
Acceptability Assessed Via Qualitative Exit Interview- Number of Participants Who Completed Interview
Qualitative exit interview to assess patient reported satisfaction with intervention content, intervention delivery, and study procedures
Week 4
Secondary Outcomes (1)
Self-reported Medication Adherence
Baseline, 4 weeks
Study Arms (1)
Values-affirmation
EXPERIMENTALInterventions
Participants will engage in a brief values-affirmation exercise to target personal motivation and openness to medication adherence. The interventionist will then review tailored medication education and individual skills training recommendations. Following the intervention session, participants will receive electronic pill box(es) that are labeled with the participants' most important core value(s) and will be asked to use these pill box(es) to take their HF medications for 4 weeks.
Eligibility Criteria
You may qualify if:
- Heart failure
- Enrolled in cardiac rehabilitation
- Read and understand English
- At risk for medication non-adherence based on self-report screening or number of prescribed medications
You may not qualify if:
- Current participation in another medication-monitoring clinical or research protocol
- New York Heart Association class IV heart failure
- Diagnosis of Alzheimer's, dementia, or severe cognitive impairment indicated on screening
- Current suicidality or psychosis
- Terminal illness with an expected lifespan of less than 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Miriam Hospitallead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
The Miriam Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Emily Gathright, PhD
- Organization
- The Miriam Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2022
First Posted
April 5, 2022
Study Start
February 23, 2022
Primary Completion
August 11, 2022
Study Completion
August 11, 2022
Last Updated
June 22, 2023
Results First Posted
June 22, 2023
Record last verified: 2022-09